biospecimen__admin__batch_number	405.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	1ACA9F0B-AC58-446D-A039-AA76ECAA393C
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-AADW-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-AADW-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-AADW-01A
biospecimen__bio__biospecimen_barcode_bottom	0167788081
biospecimen__bio__day_of_creation	31
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	03
biospecimen__bio__month_of_shipment	04
biospecimen__bio__pathology_report_file_name	TCGA-DD-AADW.18DA1A83-81E4-462C-AA58-FBB1298F86F9.pdf
biospecimen__bio__plate_column	2
biospecimen__bio__plate_id	A39J
biospecimen__bio__plate_row	D
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-DD-AADW
biospecimen__shared__patient_id	AADW
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	AF56212A-8134-4133-A3E0-D7032332D4F1
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.8
clinical__chol_lihc_shared__albumin_result_specified_value	4.3
clinical__chol_lihc_shared__albumin_result_upper_limit	4.3
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.8
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	8
clinical__chol_lihc_shared__fetoprotein_outcome_value	250
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	1.0
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.0
clinical__chol_lihc_shared__platelet_result_lower_limit	130
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	48
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-AADW-F68408
clinical__clin_shared__bcr_followup_uuid	44153E18-60CB-4599-B0A5-CEF3F6CA083D
clinical__clin_shared__day_of_form_completion	17
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	7
clinical__clin_shared__platelet_result_count	102
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	No
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	d58a6b3b-359d-4002-b87c-835d830c8a99
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-AADW-01A-11R-A39J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	512effa1-8549-4e6c-9098-7fcc77cf32ce
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.86
gdc__analytes__analyte_id	61e27060-b654-40fb-8045-c51942aadf6a
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	1bcf1762-7926-45f6-a367-d45fc3af7bc3
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:31:12.037302-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	b8155630-1e4c-5069-9d1a-6acb8904f279
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1965
gdc__diagnoses__age_at_diagnosis	17781
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-17781.0
gdc__diagnoses__days_to_last_follow_up	587.0
gdc__diagnoses__diagnosis_id	65079aa3-1f22-5aab-92cf-13129f2994c3
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	18.442545824080693
gdc__exposures__exposure_id	109dc8ab-2a96-5958-ace1-63e289e66e77
gdc__exposures__height	163.0
gdc__exposures__weight	49.0
gdc__file_id	a14e24f0-5fc4-4ec1-905b-57c5023fd21e
gdc__file_name	efbb2c7f-fc73-4115-a161-b76fec920b49.mirbase21.mirnas.quantification.txt
gdc__file_size	50412
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	ddf0e7fedb0dfa15f9d7dfba8f338030
gdc__portions__is_ffpe	false
gdc__portions__portion_id	c7a413de-1854-4c93-8e27-fa1e0b98b844
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	287
gdc__samples__initial_weight	30.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	18DA1A83-81E4-462C-AA58-FBB1298F86F9
gdc__samples__sample_id	db312a8d-28b5-4828-9731-5a175eb2c517
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	75.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	c311e060-43ae-47fe-84a3-86c69ed10ecf
gdc__submitter_id	mirna_swap_dr11_102_MirnaExpression462bfa35-7c00-44d2-9bcf-fe662c2034d7_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	c42c3aef-9203-52b9-ae51-b3a040847f2d
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:24.322+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/d58a6b3b-359d-4002-b87c-835d830c8a99-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/d58a6b3b-359d-4002-b87c-835d830c8a99-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129783
manually_curated__local_md5	4c3d94ee42872f08147f99c6db7c5481
manually_curated__opengdc_download_date	2018-10-16T17:12:10.000248+02:00
manually_curated__opengdc_file_md5	4290ea5b2d0052ec8852b017ce3422d7
manually_curated__opengdc_file_size	50411
manually_curated__opengdc_id	d58a6b3b-359d-4002-b87c-835d830c8a99-meq
manually_curated__origin_file_size	129783
manually_curated__origin_last_modified_date	Tue Oct 16 17:21:00 CEST 2018
manually_curated__origin_md5	4c3d94ee42872f08147f99c6db7c5481
manually_curated__tissue_status	tumoral
